Reasons for ibrutinib therapy discontinuation in patients with chronic lymphocytic leukemia
2/27/2015
About 10 percent of patients with chronic lymphocytic leukemia (CLL) discontinued therapy with the Bruton tyrosine kinase (BTK) inhibitor drug ibrutinib because of disease progression during...
MDs' recommendations on HPV vaccine carry weight with college students
2/27/2015
College students say they would follow their doctor's recommendations concerning the human papillomavirus (HPV) vaccine, a currently underutilized opportunity for cancer prevention.
Reasons for ibrutinib therapy discontinuation in patients with chronic lymphocytic leukemia
2/27/2015
About 10 percent of patients with chronic lymphocytic leukemia (CLL) discontinued therapy with the Bruton tyrosine kinase (BTK) inhibitor drug ibrutinib because of disease progression during...
MDs' recommendations on HPV vaccine carry weight with college students
2/27/2015
College students say they would follow their doctor's recommendations concerning the human papillomavirus (HPV) vaccine, a currently underutilized opportunity for cancer prevention.
TGen study: Destroying tumor material that 'cloaks' cancer cells could benefit patients
2/27/2015
Eliminating 'stroma' could enable anti-cancer drugs to penetrated tumor tissues; improve treatments and extend patient survivalLike a stealth jet cloaks itself from radar, cancer cells cloak...
Culture clash: How stem cells are grown affects their genetic stability
2/27/2015
Methods to multiply pluripotent cells for potential therapies raise worries about cancerThe therapeutic promise of human stem cells is indisputably huge, but the process of translating their...
New health care delivery model for prostate cancer care results in better patient outcomes
2/27/2015
Population-based approach includes safety-net program, improved surgical procedures to help improve patient outcomesA comprehensive, population-based regional health care management program for...
Graphene shows potential as novel anti-cancer therapeutic strategy
2/27/2015
University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells.
Together, nanotechnology and genetic interference may tackle 'untreatable' brain tumors
2/27/2015
Tel Aviv University researchers' groundbreaking strategy stops brain tumor cell proliferation with targeted nanoparticlesThere are no effective available treatments for sufferers of Glioblastoma...
Cutting-edge technology optimizes cancer therapy with nanomedicine drug combinations
2/27/2015
UCLA bioengineers develop platform that offers personalized approach to treatmentIn greater than 90 percent of cases in which treatment for metastatic cancer fails, the reason is that the cancer...